Can a gentle cream outperform harsh acne drugs?

NCT ID NCT07759505

First seen Aug 12, 2026 · Last updated Aug 13, 2026 · Updated 1 time

Summary

This study evaluates a new dermocosmetic cream containing 15% azelaic acid in people with mild-to-moderate acne. Researchers will observe how well the cream reduces acne lesions and improves skin discoloration, and how well it is tolerated, compared to standard treatments like oral or topical acne medications. The study follows participants over 84 days in routine care settings to see if the cream offers a comparable or better balance of effectiveness and skin tolerance.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
A dermocosmetic cream containing 15% azelaic acid and a complex of active ingredients
What this could lead to
If successful, this cream could offer a well-tolerated, non-prescription option for managing mild-to-moderate acne, potentially reducing reliance on stronger drugs.
What could go wrong
This is a small pilot study, so results may not apply broadly. The cream's effectiveness compared to standard treatments is uncertain, and skin irritation is a possible side effect.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACNE VULGARIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

acne Acne Vulgaris

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • CMI Dermato-Venerologie, Hatami Kaleshtari Mohammad

    Bucharest, 021391, Romania

More trials for these conditions

Other studies related to the condition(s) this trial covers.